Le Lézard
Classified in: Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Box Sets Date to Announce Fourth Quarter and Fiscal 2024 Financial Results


Box, Inc. (NYSE:BOX) today announced that it will report financial results for its fourth quarter and full fiscal year, which ended January 31, 2024, following the close of the market on Tuesday, March 5, 2024. On that day, Box's management will hold a conference call and webcast at 2:00 p.m. PT to discuss Box's financial results and business developments.

The conference call can be accessed by registering online at https://events.q4inc.com/attendee/453103508, at which time registrants will receive dial-in information as well as a conference ID.

What:

Box Fourth Quarter and Fiscal 2024 Earnings Conference Call

When:

Tuesday, March 5, 2024

Time:

2:00 p.m. PT

Webcast:

www.boxinvestorrelations.com

A live webcast will be accessible from the Box investor relations website at www.boxinvestorrelations.com. A replay will be available at (800) 770-2030 (toll-free), (609) 800-9909 (US toll), or (647) 362-9199 (Canada toll) with conference ID 23531 until 8:59 p.m. (ET) on March 12, 2024.

About Box

Box (NYSE:BOX) is the leading Content Cloud, a single platform that empowers organizations to manage the entire content lifecycle, work securely from anywhere, and integrate across best-of-breed apps. Founded in 2005, Box simplifies work for leading global organizations, including AstraZeneca, JLL, Morgan Stanley, and Nationwide. Box is headquartered in Redwood City, CA, with offices across the United States, Europe, and Asia. Visit box.com to learn more. And visit box.org to learn more about how Box empowers nonprofits to fulfill their missions.

Safe Harbor for Forward-Looking Statements

During the course of this event, Box will make forward-looking statements regarding future events or the future financial performance of the company. Statements including words such as "anticipate," "believe," "estimate," or "expect" and statements in the future tense are forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual events or actual future results to differ materially from those set forth in the forward-looking statements. Please refer to Box's latest Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2023 for a discussion of important factors that could cause actual events or actual results to differ materially from those discussed during this event. These forward-looking statements speak only as of the date of the event; Box assumes no obligation, and does not necessarily intend, to update these forward-looking statements.


These press releases may also interest you

at 12:10
Xsolla, a global video game commerce company, announces a new partnership with Curve Games, the award-winning London-based publisher of several notable independent games. The alliance will leverage Xsolla's Web Shop to support Curve Games in...

at 12:05
Mintegral, a programmatic subsidiary of leading advertising technology company Mobvista (1860.HK), has launched an advanced model for precise user acquisition (UA). The new model, Target CPE (Cost Per Engagement), helps advertisers achieve lifetime...

at 12:00
Ekinops (Euronext Paris: EKI) (ISIN: FR0011466069), a leading supplier of optical transport and enterprise connectivity solutions for telecom operators and enterprises, today announced that Orange Business has chosen Ekinops technology to launch its...

at 12:00
Trianz, a global digital transformation technology solutions and services firm, is thrilled to announce the appointment of Priyanshu Singh as its new VP & Chief of Staff. This strategic hire comes at a pivotal moment as Trianz continues to experience...

at 12:00
Marelli, a leading global mobility technology supplier, announced that Kelei Shen is assuming the role of Executive Vice President and President China effective July 1, 2024. He will lead Marelli's ambitious growth plans for China....

at 11:56
Northwest Biotherapeutics ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, reported positive results of voting at the Annual Shareholders Meeting on June 29, 2024. ...



News published on and distributed by: